Immunohistochemical Expression of Langerin in Langerhans Cell Histiocytosis and Non-Langerhans Cell Histiocytic Disorders

@article{Lau2008ImmunohistochemicalEO,
  title={Immunohistochemical Expression of Langerin in Langerhans Cell Histiocytosis and Non-Langerhans Cell Histiocytic Disorders},
  author={Sean K Lau and Peiguo G. Chu and Lawrence Martin Weiss},
  journal={The American Journal of Surgical Pathology},
  year={2008},
  volume={32},
  pages={615-619}
}
Langerin is a type II transmembrane C-type lectin associated with the formation of Birbeck granules in Langerhans cells. Langerin is a highly selective marker for Langerhans cells and the lesional cells of Langerhans cell histiocytosis. Although Langerin protein expression in Langerhans cell histiocytosis has been previously documented, the specificity of Langerin expression as determined by immunohistochemistry in the context of other histiocytic disorders has not been well established. In the… Expand
p53 Is a Helpful Marker in Distinguishing Langerhans Cell Histiocytosis From Langerhans Cell Hyperplasia
TLDR
CD31, if positive in the dermal infiltrate, is suggestive of a diagnosis of LCH, but exhibits a relatively low sensitivity for this purpose; p53 proved to be a helpful and accurate diagnostic immunohistochemical stain when distinguishing between LCH and LC hyperplasia. Expand
Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis.
TLDR
It is suggested that a subset of cases of Langerhans cell histiocytosis may be treated with tyrosine kinase inhibitors due to the expression of platelet-derived growth factor receptor α. Expand
Co-occurrence of Langerhans cell histiocytosis and Rosai–Dorfman disease: possible relationship of two histiocytic disorders in rare cases
TLDR
Evidence is suggested on the basis of evidence from nine additional cases of concurrent Langerhans cell histiocytosis and Rosai–Dorfman disease that the two entities may be pathophysiologically related. Expand
CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells
TLDR
It is concluded that cyclinD1 is an efficient marker to differentiate neoplastic from reactive LC proliferation, and can be used as a surrogate marker in LCH. Expand
Localized eosinophilic (Langerhans' cell) granuloma of the lower lip. A lesion that may cause diagnostic error
TLDR
Labial eosinophilic (Langerhans’ cell) granuloma should be considered in the histological differential diagnosis in cases with atypical polymorphous infiltrates including large pale cells. Expand
Langerhans cell histiocytosis: Diagnosis and Management
TLDR
Treatment of LCH is multimodal, determined based on age, extent of lesion, organ involvement, and organ location. Expand
Pulmonary histiocytic sarcoma mimicking pulmonary Langerhans cell histiocytosis in a young adult presenting with spontaneous pneumothorax: a potential diagnostic pitfall
TLDR
A case of a histiocytic sarcoma incidentally detected in peripheral lung tissue resected for a spontaneous pneumothorax is presented, emphasising the importance of proving the diagnosis of pulmonary Langerhans cell Histiocytosis by means of immunohistochemistry. Expand
Non‐Langerhans cell histiocytosis with isolated CNS involvement: An unusual variant of Erdheim‐Chester disease
TLDR
A 58‐year‐old Caucasian woman who presented with diabetes insipidus and was found to harbor a large suprasellar mass was reported, consistent with non‐LCH, and a diagnosis of Erdheim‐Chester disease was made. Expand
Adult Multisystem Langerhans Cell Histiocytosis
Langerhans cell histiocytosis is a rare histiocytic disorder, characterised by histiocyte infiltration of the body organ. Although this disease has been diagnosed in all age groups, it is most commonExpand
Langerhans Cell Histiocytosis: a Case Report
TLDR
A 29-year-old man with Langerhans cell histiocytosis with an onset at the age of 8, which later progressed to a multisystem disease, and a favorable therapeutic response was obtained after systemic corticosteroid therapy. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Diagnostic relevance of Langerin detection in cells from bronchoalveolar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis
TLDR
Evidence is provided for the usefulness of Langerin-directed immuno- and glycohistochemical monitoring of bronchoalveolar lavage fluid in the diagnosis of pulmonary Langerhans cell histiocytosis. Expand
Differentiation of Langerhans cells in Langerhans cell histiocytosis.
TLDR
It is concluded that LCH cells in the bone and/or chronic forms of the disease accumulate within the tissues in an immature state and that most probably result from extrinsic signals and may be induced to differentiate toward mature DCs after CD40 triggering. Expand
Langerin (CD207) Staining in Normal Pediatric Tissues, Reactive Lymph Nodes, and Childhood Histiocytic Disorders
  • K. Chikwava, R. Jaffe
  • Biology, Medicine
  • Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
  • 2004
TLDR
It is concluded that Langerin is coexpressed with CD1a on LCs and LCH, and when used alone to confirm LCH infiltration, the 12D6 antibody should be used with caution. Expand
Immunohistochemical Analysis of Langerin in Langerhans Cell Histiocytosis and Pulmonary Inflammatory and Infectious Diseases
TLDR
Examination of expression patterns of S100, CD1a, and langerin in LCH and other interstitial, inflammatory, and infectious processes in cases retrieved from the files at Brigham and Women's Hospital Department of Pathology found Langerin andCD1a serve as specific diagnostic markers in distinguishing LCH from other interinterstitial and inflammatory processes. Expand
Coexpression of CD1a, langerin and Birbeck's granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies.
TLDR
In the examined 11 cases co-expression of CD1a with langerin and with the presence of Birbeck's granules was noted, and the results corroborate the usefulness of immunocytochemical studies on CD 1 a and langersin expression in diagnosis of LCH. Expand
Langerin+ versus CD1a+ Langerhans cells in human gingival tissue: a comparative and quantitative immunohistochemical study.
TLDR
The present study has revealed the heterogeneity in the phenotype of gingival LC population and shown that Langerin seems the most specific marker for the study of LC. Expand
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.
Pathologists and pediatric hematologist/ oncologists of the World Health Organization's Committee on Histiocytic/Reticulum Cell Proliferations and the Reclassification Working Group of the HistiocyteExpand
Langerin/CD207 sheds light on formation of birbeck granules and their possible function in langerhans cells
TLDR
Langerin is a potent LC-specific regulator of membrane superimposition and zippering, representing a key molecule to trace LCs and to probe BG function. Expand
Reactivity of Langerhans cells with hybridoma antibody.
TLDR
This monoclonal antibody was unreactive with non-Ia-bearing epidermal cells and with peripheral blood B cells, T cells, and monocytes but did not bind to 70% of intrathymic lymphocytes, which further distinguish Langerhans cells from classical monocytes. Expand
The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface
We generated monoclonal antibody (mAb) DCGM4 by immunization with human dendritic cells (DC) from CD34+ progenitors cultured with granulocyte‐macrophage colony‐stimulating factor and TNF‐α. mAb DCGM4Expand
...
1
2
3
...